PMC:7652766 / 94940-95134 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3485","span":{"begin":72,"end":80},"obj":"Disease"}],"attributes":[{"id":"A3485","pred":"tao:has_database_id","subj":"3485","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" RdRp inhibitor, has also been clinically assessed and was approved for COVID-19 treatment in China, March 2020 (331, 332). An experimental study carried out with the VERO cell line showed that "}